Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth R Durbin

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Nature Methods|March 4, 2020
Multiplexed mass spectrometry of individual ions improves measurement of proteoforms and their complexesJared O Kafader, Rafael D Melani, Kenneth R Durbin, et al.
Nature Chemical Biology|April 4, 2025
Native top-down proteomics enables discovery in endocrine-resistant breast cancerFabio P Gomes, Kenneth R Durbin, Kevin Schauer, et al.
Science Advances|August 10, 2022
Highly multiplexed, label-free proteoform imaging of tissues by individual ion mass spectrometryPei Su, John P McGee, Kenneth R Durbin, et al.
Molecular & Cellular Proteomics : MCP|January 1, 2020
Thorough Performance Evaluation of 213 nm Ultraviolet Photodissociation for Top-down ProteomicsLuca Fornelli, Kristina Srzentić, Timothy K Toby, et al.
Nature|November 1, 2011
Mapping intact protein isoforms in discovery mode using top-down proteomicsJohn C Tran, Leonid Zamdborg, Dorothy R Ahlf, et al.
Nature Methods|January 19, 2016
An informatic framework for decoding protein complexes by top-down mass spectrometryOwen S Skinner, Pierre C Havugimana, Nicole A Haverland, et al.
Molecular Cancer Therapeutics|February 28, 2018
Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug ConjugateAndrew C Phillips, Erwin R Boghaert, Kedar S Vaidya, et al.
Proteomics|March 20, 2014
The first pilot project of the consortium for top-down proteomics: a status reportXibei Dang, Jenna Scotcher, Si Wu, et al.
Science Advances|October 4, 2024
BCL-X<sub>L</sub>-targeting antibody-drug conjugates are active in preclinical models and mitigate on-mechanism toxicity of small-molecule inhibitorsAndrew S Judd, Bhupinder Bawa, Wayne R Buck, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Nature Methods|March 4, 2020
Multiplexed mass spectrometry of individual ions improves measurement of proteoforms and their complexesJared O Kafader, Rafael D Melani, Kenneth R Durbin, et al.
Nature Chemical Biology|April 4, 2025
Native top-down proteomics enables discovery in endocrine-resistant breast cancerFabio P Gomes, Kenneth R Durbin, Kevin Schauer, et al.
Science Advances|August 10, 2022
Highly multiplexed, label-free proteoform imaging of tissues by individual ion mass spectrometryPei Su, John P McGee, Kenneth R Durbin, et al.
Molecular & Cellular Proteomics : MCP|January 1, 2020
Thorough Performance Evaluation of 213 nm Ultraviolet Photodissociation for Top-down ProteomicsLuca Fornelli, Kristina Srzentić, Timothy K Toby, et al.
Nature|November 1, 2011
Mapping intact protein isoforms in discovery mode using top-down proteomicsJohn C Tran, Leonid Zamdborg, Dorothy R Ahlf, et al.
Nature Methods|January 19, 2016
An informatic framework for decoding protein complexes by top-down mass spectrometryOwen S Skinner, Pierre C Havugimana, Nicole A Haverland, et al.
Molecular Cancer Therapeutics|February 28, 2018
Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug ConjugateAndrew C Phillips, Erwin R Boghaert, Kedar S Vaidya, et al.
Proteomics|March 20, 2014
The first pilot project of the consortium for top-down proteomics: a status reportXibei Dang, Jenna Scotcher, Si Wu, et al.
Science Advances|October 4, 2024
BCL-X<sub>L</sub>-targeting antibody-drug conjugates are active in preclinical models and mitigate on-mechanism toxicity of small-molecule inhibitorsAndrew S Judd, Bhupinder Bawa, Wayne R Buck, et al.
Pageof 6